Full Text
Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK- A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

Abstract

Authors

JD Marshall J Clayton

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×